Sunshine Guojian Pharmaceutical Shanghai Co.’s Listing on STAR Market on the Shanghai Stock Exchange

Baker McKenzie advised 3SBio Inc. on the deal.

Sunshine Guojian Pharmaceutical Shanghai Co., Ltd., executed its proposed listing on the STAR market on the Shanghai Stock Exchange.

The spin-off listing of Sunshine Guojian on the STAR market and the offering of its securities have been completed.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. manufactures biotechnology products, and produces vaccines, toxoids, antibody drugs, and other products.

The Baker McKenzie team was led by partner Ivy Wong (Picture), associates William Cho and Karen Wong, Daisy Chen, assistant Albert Tang and paralegal Audrey Ng.

Involved fees earner: Daisy Chen – Baker McKenzie; William Cho – Baker McKenzie; Albert Tang – Baker McKenzie; Ivy Wong – Baker McKenzie; Karen Wong – Baker McKenzie;

Law Firms: Baker McKenzie;

Clients: 3SBio Inc.;

Author: Michael Patrini